Nader Yatim

7.1k total citations · 1 hit paper
17 papers, 1.9k citations indexed

About

Nader Yatim is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Nader Yatim has authored 17 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Nader Yatim's work include interferon and immune responses (4 papers), Cell death mechanisms and regulation (4 papers) and Immunotherapy and Immune Responses (4 papers). Nader Yatim is often cited by papers focused on interferon and immune responses (4 papers), Cell death mechanisms and regulation (4 papers) and Immunotherapy and Immune Responses (4 papers). Nader Yatim collaborates with scholars based in France, United States and United Kingdom. Nader Yatim's co-authors include Matthew L. Albert, Sean P. Cullen, Andrew Oberst, Douglas R. Green, Rosa Barreira da Silva, Susana Orozco, Oliver Schulz, Caetano Reis e Sousa, Stephen W. G. Tait and Molly A. Ingersoll and has published in prestigious journals such as Science, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Nader Yatim

15 papers receiving 1.9k citations

Hit Papers

RIPK1 and NF-κB signaling in dying cells determines cross... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nader Yatim France 12 1.1k 917 539 325 193 17 1.9k
Conor J. Kearney Australia 20 1.1k 0.9× 978 1.1× 598 1.1× 194 0.6× 108 0.6× 30 1.9k
Qi‐Xiang Li China 25 875 0.8× 346 0.4× 587 1.1× 222 0.7× 259 1.3× 73 1.8k
Jennifer L. Guerriero United States 19 1.0k 0.9× 1.2k 1.3× 1.2k 2.2× 156 0.5× 249 1.3× 50 2.5k
Eszter Lázár‐Molnár United States 19 608 0.5× 1.1k 1.2× 1.1k 2.0× 269 0.8× 191 1.0× 40 2.2k
Hirotake Tsukamoto Japan 23 654 0.6× 910 1.0× 620 1.2× 118 0.4× 125 0.6× 54 1.7k
Martin K. Thomsen Denmark 23 992 0.9× 607 0.7× 241 0.4× 286 0.9× 270 1.4× 45 1.8k
Krishna Kadaveru United States 9 1.1k 1.0× 935 1.0× 873 1.6× 132 0.4× 147 0.8× 11 2.1k
Xin He China 27 1.3k 1.2× 500 0.5× 456 0.8× 171 0.5× 99 0.5× 132 2.4k
Ryan D. Chow United States 21 1.2k 1.0× 355 0.4× 661 1.2× 120 0.4× 216 1.1× 40 1.9k
Birgit Fehrenbacher Germany 21 1.2k 1.1× 464 0.5× 489 0.9× 258 0.8× 368 1.9× 50 2.2k

Countries citing papers authored by Nader Yatim

Since Specialization
Citations

This map shows the geographic impact of Nader Yatim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nader Yatim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nader Yatim more than expected).

Fields of papers citing papers by Nader Yatim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nader Yatim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nader Yatim. The network helps show where Nader Yatim may publish in the future.

Co-authorship network of co-authors of Nader Yatim

This figure shows the co-authorship network connecting the top 25 collaborators of Nader Yatim. A scholar is included among the top collaborators of Nader Yatim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nader Yatim. Nader Yatim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Alonso, Ruby, Zacarias Garcia, Béatrice Corre, et al.. (2025). Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control. Science Advances. 11(33). eadv0871–eadv0871.
2.
Park, Matthew D., Nader Yatim, Jing Zhang, et al.. (2025). Restoring resident tissue macrophages to combat aging and cancer. Nature Aging. 5(8). 1383–1392. 2 indexed citations
3.
Robert, M, Nader Yatim, Karim Sacré, & Darragh Duffy. (2024). Sarcoidosis immunopathogenesis – a new concept of maladaptive trained immunity. Trends in Immunology. 45(6). 406–418. 5 indexed citations
4.
Stolzenberg, Marie‐Claude, Jérôme Hadjadj, Laura Barnabei, et al.. (2023). L’haploinsuffisance en SHARPIN est responsable d’un déficit partiel en LUBAC, de manifestations inflammatoires, d’une auto-immunité et d’un défaut de production d’anticorps. La Revue de Médecine Interne. 44. A329–A329. 1 indexed citations
5.
Boussier, Jérémy, Nader Yatim, A. Marchal, et al.. (2021). Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. Journal of Allergy and Clinical Immunology. 149(2). 550–556.e2. 25 indexed citations
6.
Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations
7.
Frumholtz, L., Jean‐David Bouaziz, Maxime Battistella, et al.. (2020). Activation endothéliale associée aux ANCA IgA au cours des lésions de lésions acrales pendant l’épidémie de COVID-19. Annales de Dermatologie et de Vénéréologie. 147(12). A110–A110.
8.
Orozco, Susana, Brian P. Daniels, Nader Yatim, et al.. (2019). RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane Integrity. Cell Reports. 28(9). 2275–2287.e5. 90 indexed citations
9.
Boussier, Jérémy, et al.. (2018). Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes. Cell Death and Disease. 9(5). 539–539. 20 indexed citations
10.
Alloatti, Andrés, Derek C. Rookhuizen, Leonel Joannas, et al.. (2017). Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. The Journal of Experimental Medicine. 214(8). 2231–2241. 95 indexed citations
11.
Yatim, Nader, Sean P. Cullen, & Matthew L. Albert. (2017). Dying cells actively regulate adaptive immune responses. Nature reviews. Immunology. 17(4). 262–275. 337 indexed citations
12.
Yatim, Nader, Christine Mateus, & Pierre Charles. (2017). Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission. La Revue de Médecine Interne. 39(2). 130–133. 28 indexed citations
13.
Silva, Rosa Barreira da, Melissa E. Laird, Nader Yatim, et al.. (2015). Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nature Immunology. 16(8). 850–858. 241 indexed citations
14.
Yatim, Nader, Susana Orozco, Oliver Schulz, et al.. (2015). RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8 + T cells. Science. 350(6258). 328–334. 493 indexed citations breakdown →
15.
Orozco, Susana, Nader Yatim, Stephen W. G. Tait, et al.. (2014). RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death and Differentiation. 21(10). 1511–1521. 231 indexed citations
16.
Tait, Stephen W. G., Andrew Oberst, Giovanni Quarato, et al.. (2013). Widespread Mitochondrial Depletion via Mitophagy Does Not Compromise Necroptosis. Cell Reports. 5(4). 878–885. 249 indexed citations
17.
Yatim, Nader, et al.. (2011). Dying to Replicate: The Orchestration of the Viral Life Cycle, Cell Death Pathways, and Immunity. Immunity. 35(4). 478–490. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026